Promedius Inc.

Promedius Inc. is a MedTech startup with a slogan of "A New Vision for Osteoporosis." Founded in 2019 and headquartered in Korea South, the company has attracted the attention of MedTech Innovator who provided a Non Equity Assistance investment at 29 May 2024.

Promedius aims to revolutionize the field of age-related conditions, particularly in the area of osteoporosis. Their groundbreaking technology, PROSⓇ CXR: OSTEO, is the world's first screening solution that uses chest X-ray images to identify individuals at risk of osteoporosis. This innovative approach enables the proactive identification of potential patients at risk, addressing the challenges associated with osteoporosis.

Furthermore, the company's PROSⓇ CT: MQ solution leverages abdominal CT images to assess the quality of fat and muscle, providing essential body composition information without additional radiation exposure. This not only has implications for osteoporosis management but also for impacting metabolic state.